Cellenkos is an early stage clinical biotechnology company that focuses on umbilical cord blood derived T-regulatory cellular therapies for treating autoimmune diseases and inflammatory disorders.
Cellenkos, Inc.
Management
Technology
Deals/Partnering
Research Pipeline
Funding
BioStartup's Score
0 / 50
KEY DETAILS
Websitehttp://www.cellenkosinc.com
Founded2016
Disease Focus
Development StagePreclinical
STOCK CODENon Listed
Address5416 Chaucer Drive, TX 77005HoustonUnited States
5416 Chaucer Drive, TX 77005
Houston
United States
Contact Number+1 800 217-8247
+1 800 217-8247
[atom_linkedin linkedin_option=”CompanyInsider” linkedin_id=” ” connections=”true” suffix=””]